Postretrieval Microinjection of Baclofen Into the Agranular Insular Cortex Inhibits Morphine-Induced CPP by Disrupting Reconsolidation.
agranular insular cortex
baclofen
conditioned place preference
morphine addiction
reconsolidation
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2020
2020
Historique:
received:
20
12
2019
accepted:
04
05
2020
entrez:
9
6
2020
pubmed:
9
6
2020
medline:
9
6
2020
Statut:
epublish
Résumé
Environmental cues associated with drug abuse are powerful mediators of drug craving and relapse in substance-abuse disorders. Consequently, attenuating the strength of cue-drug memories could reduce the number of factors that cause drug craving and relapse. Interestingly, impairing cue-drug memory reconsolidation is a generally accepted strategy aimed at reducing the intensity of cues that trigger drug-seeking and drug-taking behaviors. In addition, the agranular insular cortex (AI) is an important component of the neural circuits underlying drug-related memory reconsolidation. GABA
Identifiants
pubmed: 32508658
doi: 10.3389/fphar.2020.00743
pmc: PMC7248341
doi:
Types de publication
Journal Article
Langues
eng
Pagination
743Informations de copyright
Copyright © 2020 Sun, Mu, Chang, Zhang, Wang, Rong, Liu, Zuo, He, Wan, Yang, Wang and Sun.
Références
J Neurobiol. 1995 Mar;26(3):403-12
pubmed: 7775973
Eur J Pharmacol. 2012 Jan 15;674(2-3):321-6
pubmed: 22119382
J Neurosci. 2002 May 15;22(10):3969-76
pubmed: 12019316
Neuroscience. 2009 Jan 23;158(2):369-72
pubmed: 19041372
Compr Psychiatry. 2020 Jan;96:152135
pubmed: 31810026
Dev Reprod. 2015 Jun;19(2):61-7
pubmed: 27004262
Psychopharmacology (Berl). 2017 Aug;234(16):2431-2441
pubmed: 28462472
J Comp Neurol. 1998 Oct 5;399(4):440-68
pubmed: 9741477
Behav Brain Res. 2013 Nov 1;256:188-96
pubmed: 23968590
Arch Gen Psychiatry. 2005 Jul;62(7):761-8
pubmed: 15997017
Front Behav Neurosci. 2019 Oct 15;13:242
pubmed: 31680897
Psychopharmacology (Berl). 2013 Apr;226(4):659-72
pubmed: 22638814
Neuropsychopharmacology. 2007 Feb;32(2):388-98
pubmed: 16710312
Behav Brain Res. 2015 Oct 15;293:203-7
pubmed: 26210935
Front Behav Neurosci. 2016 Mar 15;10:50
pubmed: 27014010
Nat Neurosci. 2020 Jan;23(1):32-46
pubmed: 31792465
Neuropsychopharmacology. 2012 Aug;37(9):2101-8
pubmed: 22534623
J Neurosci. 2012 May 30;32(22):7577-84
pubmed: 22649236
Exp Neurol. 2019 Jan;311:234-246
pubmed: 30342963
Anal Bioanal Chem. 2014 Feb;406(5):1339-54
pubmed: 23912828
Neuroscience. 2010 Apr 14;166(4):1140-57
pubmed: 20105453
Behav Brain Funct. 2017 Apr 17;13(1):7
pubmed: 28416021
Curr Opin Neurobiol. 2011 Apr;21(2):339-44
pubmed: 21376567
Neuropsychopharmacology. 2013 Aug;38(9):1780-8
pubmed: 23546387
Trends Cogn Sci. 2009 Aug;13(8):334-40
pubmed: 19643659
Trends Cogn Sci. 2015 Aug;19(8):475-82
pubmed: 26170029
Front Pharmacol. 2018 Jan 04;8:924
pubmed: 29354053
Neuropharmacology. 2016 Feb;101:1-12
pubmed: 26365570
Front Behav Neurosci. 2013 Sep 09;7:118
pubmed: 24058336
Cell Rep. 2013 Mar 28;3(3):607-14
pubmed: 23478024
Neuron. 2015 Oct 7;88(1):47-63
pubmed: 26447572
J Neurosci. 2005 Dec 14;25(50):11757-67
pubmed: 16354934
Physiol Rev. 2009 Apr;89(2):411-52
pubmed: 19342611
J Neurosci. 2010 Mar 24;30(12):4401-7
pubmed: 20335476
Anat Rec (Hoboken). 2013 Mar;296(3):378-81
pubmed: 23382140
Neuroscience. 2016 Aug 4;329:326-36
pubmed: 27208619
Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3245-55
pubmed: 18640924
Neuropsychopharmacology. 2020 Mar;45(4):579-588
pubmed: 31593982
Sci Rep. 2015 Nov 05;5:16283
pubmed: 26538334
Ann N Y Acad Sci. 2014 May;1316:53-70
pubmed: 24690001
Science. 2007 Jan 26;315(5811):531-4
pubmed: 17255515
Pharmacol Biochem Behav. 2019 Oct;185:172759
pubmed: 31415776
PLoS One. 2011;6(9):e24865
pubmed: 21980362
Alcohol Alcohol. 2002 Sep-Oct;37(5):478-84
pubmed: 12217943
Psychopharmacology (Berl). 2011 May;215(1):117-28
pubmed: 21181127
J Neurosci. 2010 Sep 1;30(35):11771-80
pubmed: 20810897
Curr Opin Pharmacol. 2017 Aug;35:120-124
pubmed: 28874314
J Neurosci. 2020 Feb 5;40(6):1344-1354
pubmed: 31862855
Neuropharmacology. 2018 Jul 1;136(Pt A):68-79
pubmed: 29031577
Am J Drug Alcohol Abuse. 2014 Nov;40(6):428-37
pubmed: 25083822
Phys Med Biol. 2009 Dec 21;54(24):7315-27
pubmed: 19926915
Brain Res. 2003 Dec 12;993(1-2):59-71
pubmed: 14642831
Neuropsychopharmacology. 2015 Nov;40(12):2832-42
pubmed: 25953358
Neuropsychopharmacology. 2019 Feb;44(3):526-537
pubmed: 30390064
eNeuro. 2019 May 21;6(3):
pubmed: 31053606
Sheng Li Xue Bao. 2014 Oct 25;66(5):545-58
pubmed: 25332000
Proc Jpn Acad Ser B Phys Biol Sci. 2018;94(10):390-411
pubmed: 30541966
Mol Pain. 2010 Nov 04;6:75
pubmed: 21050459
Trends Cogn Sci. 2015 Jul;19(7):414-20
pubmed: 26066588
J Neurosci. 2006 May 10;26(19):5131-42
pubmed: 16687504
Trends Neurosci. 2005 Aug;28(8):436-45
pubmed: 15982754
Physiol Rev. 2004 Jul;84(3):835-67
pubmed: 15269338
Physiol Res. 2016 Nov 8;65(4):701-709
pubmed: 26988162
J Neurosci. 2012 Nov 7;32(45):16031-9
pubmed: 23136439
Addict Biol. 2019 Aug 22;:e12817
pubmed: 31436887
Front Mol Neurosci. 2019 Jul 02;12:157
pubmed: 31312119
Neuropsychopharmacology. 2020 Apr;45(5):842-850
pubmed: 31711065
Am J Psychiatry. 2018 Aug 1;175(8):729-740
pubmed: 29690790
Curr Biol. 2017 Jun 19;27(12):R580-R586
pubmed: 28633023
Addict Biol. 2019 Jul;24(4):590-603
pubmed: 29667304
Neuroscience. 2019 Jun 15;409:204-221
pubmed: 30872163
J Vis Exp. 2018 Jun 7;(136):
pubmed: 29939175
J Neurosci. 2018 Sep 26;38(39):8463-8472
pubmed: 30126972
J Neurosci. 2013 Mar 6;33(10):4295-307
pubmed: 23467346
J Neurosci. 2015 Oct 7;35(40):13773-83
pubmed: 26446228
Sci Rep. 2019 Mar 26;9(1):5180
pubmed: 30914678
Mol Neurobiol. 2018 Oct;55(10):7858-7871
pubmed: 29476450
Int J Neuropsychopharmacol. 2014 Jan;17(1):127-36
pubmed: 24103337
J Comp Neurol. 1991 Sep 1;311(1):1-16
pubmed: 1719041
Psychopharmacology (Berl). 2016 Sep;233(17):3135-47
pubmed: 27417550
Cell Rep. 2019 Jan 22;26(4):1010-1020.e5
pubmed: 30673597